research develop
market pharmaceut product custom
across wide spectrum partner end market
provid valu superior technolog
know allow compani garner lt
reason report rate chang target price chang estim
chang analysi sales/earn
solid quarter valuat push us
report anoth solid quarter result come
ahead expect across board wed note solid
cook still believ conservat
guidanc potenti out-performance rel updat
expect seem signific given current
valuat seem appropri time move
sidelin wait opportun re-ent attract
take revenu mil mil
adj ebitda guid mil mil mil mdpt
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
compani document stephen inc
mil except per share data
good sold
restructur
impair loss/ sale
provis incom tax
net incom attribut nci
net incom attribut
compani report stephen inc estim
adj ep exclud one-tim item amort purchas intang stock-bas compens
mil except per share data
corpor cost less one-tim item
percent revenu analysi
compani report stephen inc estim
million
equival
prepaid expens current asset
properti equip net
accru expens current liabil
current portion long-term debt
total liabil se
compani report stephen inc estim
million
depreci amort
increas decreas current asset
increas decreas current liabil
increas decreas certain long-term asset
increas decreas certain long-term liabil
chang debt
chang sharehold equiti
effect exchang rate
net increase/decreas
compani document stephen inc
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
